Ursprung des Netzwerks ersten Grades von Chris Parrish
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA.
8
| Holding Company | Pharmaceuticals: Other | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Chris Parrish
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd. | Information Technology Services | Director/Board Member | |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member | |
Lassen Therapeutics LLC
Lassen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Lassen Therapeutics LLC operates as a therapeutic antibody company. It discovers and develops novel medicines to treat serious unmet medical needs. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Seraxis Holdings, Inc.
Seraxis Holdings, Inc. Financial ConglomeratesFinance Seraxis Holdings, Inc. functions as an investment holding private company. The company is based in Germantown, MD. The CEO of the company is William L Rust. | Financial Conglomerates | Director/Board Member | |
Enlaza Therapeutics, Inc.
Enlaza Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and aims to deliver more efficacious and safer treatments for patients. The CEO of the company is Sergio G. Duron. | Miscellaneous Commercial Services | Director/Board Member | |
Seraxis, Inc.
Seraxis, Inc. Pharmaceuticals: MajorHealth Technology Part of Seraxis Pte Ltd., Seraxis, Inc. is a biotechnology company that specializes in developing a proprietary human stem cell line, sr1423, and manufacturing process to generate pancreatic islets that mimic native islets in purity and potency. The company is based in Germantown, MD. The company has also developed the seragraft device and other tools to enable survival and function of the islet replacement therapy in immunocompetent hosts. Seraxis aims to be the first to provide diabetics a clinical solution for glucose control and complete autonomy from insulin injections. The company was founded in 2013 by William L. Rust, who has been the CEO since 2013. | Pharmaceuticals: Major | Director/Board Member | |
FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Attovia Therapeutics
Attovia Therapeutics Medical SpecialtiesHealth Technology Attovia Therapeutics manufactures a pipeline for bio therapeutics to immune-mediated diseases including cancer. The company is based in Sacramento, CA. Attovia Therapeutics was founded by Tao Fu and Tao Fu has been the CEO since incorporation. | Medical Specialties | Director/Board Member | |
Sérum International, Inc.
Sérum International, Inc. Wholesale DistributorsDistribution Services Sérum International, Inc. operates as online shoe store. It offers Birkenstock products as well as Tatami, Newalk, Papillio, Birki's, Birki kids, Birko, Birkenstock Comfort Shoes, FP by Birkenstock and Alpro lines. The company was founded in 1962 and is headquartered in Laval, Canada. | Wholesale Distributors | Director/Board Member | |
Amunix, Inc.
Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Investment Managers | Private Equity Analyst | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Analyst | |
University of Oxford | College/University | Doctorate Degree | |
PHATHOM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Director/Board Member | |
University of Michigan | College/University | Undergraduate Degree | |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member | |
Stanford University | College/University | Corporate Officer/Principal | |
Stanford University School of Medicine | College/University | Doctorate Degree | |
Merganser Biotech, Inc.
Merganser Biotech, Inc. BiotechnologyHealth Technology Merganser Biotech, Inc. engages in the development of of hepcidin mimetic peptides as new medicines for the treatment of hematological and iron overload diseases. The company was founded by Brian R. MacDonald and Gene Merutka in 2011 and is headquartered in Newtown Square, PA. | Biotechnology | Director/Board Member | |
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
APTINYX | Pharmaceuticals: Major | Director/Board Member | |
The New York City Department of Education | General Government | Corporate Officer/Principal | |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Director/Board Member | |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member | |
FHM Life Sciences VIII LLC | Corporate Officer/Principal | ||
Mavupharma, Inc.
Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Pharmaceuticals: Major | Director/Board Member | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Consultant / Advisor | |
Cortec Group Management Services LLC
Cortec Group Management Services LLC Investment ManagersFinance Cortec Group Management Services LLC (Cortec Group) is private equity firm founded in 1984 by Richard Scott Schafler. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
Bessemer Venture Partners XII Advisors & Influencers LP | Director/Board Member | ||
Artemis Health, Inc.
Artemis Health, Inc. Internet Software/ServicesTechnology Services Artemis Health, Inc. operates as an online platform for medical claims. Its services include health care analytics, security, savings, and data aggregation. The company was founded by Gordon Grant, Dallen Allred and Regehr Dallin in 2013 and is headquartered in Salt Lake City, UT. | Internet Software/Services | Director/Board Member | |
NEUEHEALTH, INC. | Managed Health Care | Director/Board Member | |
Ginger.io, Inc.
Ginger.io, Inc. Packaged SoftwareTechnology Services Ginger.io, Inc. operates as a behavior analytics company using big data. It offers tailored technological platform for effective workflow integration. The firms continuous data collection approach detects symptom flares more precisely than regular clinic visits. The company was founded by Karan Singh, Anmol Madan and Alex Pentland in 2011 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
Recover Together, Inc.
Recover Together, Inc. Medical/Nursing ServicesHealth Services Recover Together, Inc. engages in provision of treatment to recover from opiate use. It specializes in opiate addiction treatment, Suboxone buprenorphine, and group therapy. The company was founded by Jeff De Flavio, Joy Sun and Silas Howland in 2015 and is headquartered in Nashville, TN. | Medical/Nursing Services | Director/Board Member | |
Qventus, Inc.
Qventus, Inc. Packaged SoftwareTechnology Services Qventus, Inc. provides software solutions for healthcare administration. Its solutions include forecasting and optimization, statistical monitoring and visualizations and root cause analysis. The company was founded by Mudit Garg, Ian Christopher and Brent Newhouse in 2011 and is headquartered in Mountain View, CA. | Packaged Software | Director/Board Member | |
Aspen Health, Inc.
Aspen Health, Inc. Packaged SoftwareTechnology Services Aspen Health, Inc. provides clinical pharmacy services. The company was founded by David Medvedeff and is headquartered in Lake Mary, FL. | Packaged Software | Director/Board Member |
Statistik
International
Vereinigte Staaten | 45 |
Niederlande | 3 |
Kanada | 2 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 26 |
Technology Services | 6 |
Finance | 6 |
Consumer Services | 6 |
Commercial Services | 3 |
Operativ
Director/Board Member | 107 |
Corporate Officer/Principal | 20 |
Independent Dir/Board Member | 19 |
Chairman | 12 |
Chief Tech/Sci/R&D Officer | 11 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
James Topper | 52 |
Stephen Kraus | 34 |
Alan Muney | 28 |
Steve Dubin | 25 |
Todd Creech | 19 |
Jeremy David Lack | 10 |
Alexey L. Margolin | 6 |
Daniel R. Orlando | 5 |
- Börse
- Insiders
- Chris Parrish
- Unternehmensverbindungen